Investor Information

 

Group at a Glance

Who We Are

Bespak — Devices

Aesica — Drugs

Group

Our Competitive Advantage

Consort Medical has a clear well-established growth strategy based on its leading position as a one-stop developer and manufacturer of drugs and premium drug delivery devices.

The Group’s strategy is built on four strategic priorities:

  1. Focussed sustainable organic revenue growth
  2. The potential to continue to grow margins
  3. Investment in innovation and
  4. Selective acquisitions and investments

The Group has an established competitive advantage:

Long-term, Heavily Embedded Customer Relationships

Considerable Technical Expertise And Highly Complex Manufacturing

Premium Quality and Regulatory Track Record

Strong Cash Generation

Driven by Innovation

High Barriers to Entry